Alliance Foundation Trials, Llc.
Clinical trials sponsored by Alliance Foundation Trials, Llc., explained in plain language.
-
Stronger hormone blocker combo tested to keep prostate cancer at bay
Disease control CompletedThis study tested whether adding newer, stronger hormone-blocking drugs to standard therapy could better control prostate cancer that has returned after initial surgery. It involved 504 men whose cancer was detected early through rising PSA levels but had not yet spread. The goal…
Phase: PHASE3 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New combo tested for Tough-to-Treat blood cancer
Disease control CompletedThis early-stage study aimed to find a safe dose for a new three-drug combination (ibrutinib, lenalidomide, and dexamethasone) for adults with multiple myeloma that has returned or stopped responding to prior treatments. The main goal was to check for serious side effects and det…
Phase: PHASE1 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC